H.C. Wainwright analyst issues BUY recommendation for ACET on January 21, 2026 11:11AM ET. The previous analyst recommendation was Buy.ACET was trading at $7.9 at issue of the analyst recommendation.The...
Susquehanna analyst issues POSITIVE recommendation for ARM on January 21, 2026 11:13AM ET. The previous analyst recommendation was Neutral.ARM was trading at $107.17 at issue of the analyst recommendation.The overall...
Piper Sandler analyst issues OVERWEIGHT recommendation for HWC on January 21, 2026 11:32AM ET. The previous analyst recommendation was Overweight.HWC was trading at $67.6 at issue of the analyst recommendation.The...
Goldman Sachs analyst issues NEUTRAL recommendation for NFLX on January 21, 2026 11:23AM ET. The previous analyst recommendation was Neutral.NFLX was trading at $87.26 at issue of the analyst recommendation.The...
Piper Sandler analyst issues POSITIVE recommendation for NFLX on January 21, 2026 11:29AM ET. The previous analyst recommendation was Positive.NFLX was trading at $87.26 at issue of the analyst recommendation.The...
Wells Fargo analyst issues OVERWEIGHT recommendation for MMM on January 21, 2026 11:22AM ET. The previous analyst recommendation was Overweight.MMM was trading at $156.09 at issue of the analyst recommendation.The...
RBC Capital analyst issues OUTPERFORM recommendation for AXSM on January 21, 2026 11:33AM ET. The previous analyst recommendation was Outperform.AXSM was trading at $184.5 at issue of the analyst recommendation.The...
RBC Capital analyst issues OUTPERFORM recommendation for CGON on January 21, 2026 11:34AM ET. The previous analyst recommendation was Outperform.CGON was trading at $54.69 at issue of the analyst recommendation.The...
Guggenheim analyst issues BUY recommendation for CBIO on January 21, 2026 11:34AM ET. CBIO was trading at $13.98 at issue of the analyst recommendation.The overall analyst consensus : BUY.Current analyst...
RBC Capital analyst issues OUTPERFORM recommendation for INSM on January 21, 2026 11:35AM ET. The previous analyst recommendation was Outperform.INSM was trading at $163.51 at issue of the analyst recommendation.The...
